Safety considerations for use of bone-targeted agents in patients with cancer. [electronic resource]
Producer: 20100915Description: S66-72 p. digitalISSN:- 1532-8708
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Bone Density Conservation Agents -- adverse effects
- Bone Neoplasms -- prevention & control
- Bone and Bones -- drug effects
- Denosumab
- Diphosphonates -- adverse effects
- Fever -- chemically induced
- Gastrointestinal Diseases -- chemically induced
- Humans
- Kidney Diseases -- chemically induced
- Neoplasms -- drug therapy
- RANK Ligand -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.